- Home
- Companies
- south korea
- treatment for advanced cancer
Refine by
Treatment For Advanced Cancer Suppliers Near South Korea
195 companies found
based inBaton Rouge, LOUISIANA (USA)
Oleander Medical Technologies is developing a revolutionary new treatment to destroy many of the most invasive and deadly cancers using a process called Targeted Osmotic Lysis ...
Targeted Osmotic Lysis (TOL) is a revolutionary treatment for advanced cancer, combining a generic drug (a cardiac glycoside) with a proprietary pulsed electric field ...
based in, CALIFORNIA (USA)
AIVITA Biomedical is a biotechnology company developing personalized vaccines that target COVID-19 and the seed of all cancers using our autologous cell platform. We leverage our unique expertise in stem cell growth and directed, high-purity ...
AIVITA’s immunotherapy technology creates personalized vaccines for cancer patients that target and eliminate tumor-initiating cells which are the seed of the disease. Used alone or in parallel with other treatments, AIVITA’s cancer ...
based inRiverside, CALIFORNIA (USA)
Bourns, Inc. is a leading manufacturer and supplier of automotive sensors, circuit protection solutions, magnetic products, microelectronic modules, trimming and precision potentiometers, panel controls and encoders and resistive products. ...
based inNew York, NEW YORK (USA)
Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The Protara team prioritizes creativity, diverse perspectives and tenacity to expedite our goal of bringing life-changing therapies ...
based inSan Diego, CALIFORNIA (USA)
CureMatch, Inc. is a San Diego-based digital health company focused on personalized medicine and combination therapy in oncology. CureMatch’s Decision Support System guides oncologists in the selection of cancer drugs that are customized for ...
CureMatch provides a scored and ranked listing of the most well-adapted personalized medicine treatment options. The comprehensive analysis considers commonly used treatments, as well as targeted therapy, immunotherapy, hormone therapy, and newly ...
based inEdogawa-ku, JAPAN
B dot Medical Inc. is a QST/ NIRS startup company which has the advanced technology and know-how developed and accumulated in the development of particle therapy system at NIRS. We develop the 'ultra-compact proton therapy system' that defied common ...
We are trying to overturn the image that society has of radiotherapy and proton therapy with our innovative technology. We are developing proton therapy with the hope of making it accessible to all cancer ...
based inLouvain-La-Neuve, BELGIUM
At IBA we dare to develop innovative solutions pushing back the limits of technology. We share ideas and know-how with our customers and our partners to bring new solutions for the diagnosis and treatment of cancer. We care about the well-being of ...
Proteus® has been inspired by everyday clinical practice. Through day-to-day interactions with the community, IBA is perfectly positioned to understand, and invest in, the user’s needs. These investments are directly translated into ...
based inLausanne, SWITZERLAND
Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug ...
Oxaliplatin is a diaminocyclohexane (DACH) platin. It is the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat®, which has dramatically changed the prognosis of colorectal cancer. In 1996, prior to the introduction ...
based inStockholm, SWEDEN
RaySearch® is advancing cancer treatment through pioneering software. Software has unlimited potential, and it is now the driving force for innovation in oncology. Medical science never stands still and neither does RaySearch. We work in close ...
Machine learning and data-driven oncology represents a new era in healthcare. RayIntelligence® is an innovative cloud-based oncology analytics system that gives meaning to data, empowering cancer centers to reach new levels of personalized care ...
based inChungcheongbuk-do, SOUTH KOREA
MEDITULIP focuses on clinical differentiation in minimally invasive surgery and suggests a new paradigm of cancer treatment. Since its establishment in April 2015, MEDITULIP Co., Ltd. has made remarkable achievements. Within a year since its ...
based inIssoire, FRANCE
An allogeneic platform designed to generate first in class immune therapy with the goal of harnessing the patient immune system and preventing resistance to cancer treatment. Our mission at Brenus is to provide a solution to cold solid tumors – ...
An allogeneic first in class immunotherapy harnessing the patient immune system to fight immune tolerance and prevent cancer ...
based inLittleton, MASSACHUSETTS (USA)
Mevion Medical Systems exists to deliver on the promise of proton therapy for cancer centers, clinicians and patients worldwide. We invented compact proton therapy and are continuing to transform the industry and patient care with the MEVION S250 ...
based inLondon, UNITED KINGDOM
Vision RT provides innovative Surface Guided Radiation Therapy (SGRT) solutions for cancer treatment. Vision RT was founded in 2001 with a mission to develop pioneering technology for Surface Guided Radiation Therapy (SGRT), with the goal of ...
based inSanford, FLORIDA (USA)
.decimal is a precision manufacturer of patient-specific custom beam shaping devices for proton, electron, and photon therapies used in the treatment of cancer. We are also a software development company specializing in radiation oncology planning, ...
Grid radiation therapy, using the megavoltage X-ray beam, has been proven to be an effective method for the management of large and bulky malignant tumors. This treatment modality is also known as Spatially Fractionated Radiation Therapy (SFRT). In ...
based inLos Angeles, CALIFORNIA (USA)
MiraDx partners with universities and pharmaceutical companies to utilize our unique genetic research to help better treat cancer. MiraDx was co-founded by Joanne Weidhaas, M.D., Ph.D. and Frank Slack, Ph.D. whose cutting-edge genetic research ...
Although it is completely logical that inherited, germ-line genetic differences, present in all cells, including those of the immune system, will predict response and toxicity to developing immune therapies, there has been little study of the ...
based inHalifax, NOVA SCOTIA (CANADA)
We believe in the patient above all – for their comfort and for their future. We are shaping the future of healthcare through innovative technologies that create life-changing experiences for patients all over the world. Our regulatory cleared ...
based inBasel, SWITZERLAND
T3 Pharmaceuticals was founded in May 2015 by Simon Ittig, Christoph Kasper, Marlise Amstutz and Helmut Kessmann as a spin-off of the University of Basel. The team has developed an efficient protein delivery technology that is based on the use of ...
T3 Pharma has developed a proprietary cancer therapy platform based on regulating and harnessing the natural behaviours of live bacteria. The genetically engineered bacteria selectively target solid tumors, where they deliver chosen protein payloads ...
based inWien, AUSTRIA
BlueSky Immunotherapies GmbH (Ltd.) is a clinical-stage biotech company. The company’s business is based on its own proprietary, novel technology platform for interferon-inducing viral vectors (delNS). Interferons have immunostimulatory and ...
based inBengaluru, INDIA
At OncoStem, we develop innovative prognostic tests that assess aggressiveness of tumours based on in-depth knowledge of tumour biology, to identify the unique characteristics of cancer recurrence risk. Since 2011, our vision is to empower the ...
CanAssist Breast is a prognostic test developed by OncoStem that classifies the patients as ‘low-risk’ or ‘high-risk’ based on the patient’s risk of breast cancer recurrence over five years. CanAssist Breast ...
based inSeoul, SOUTH KOREA
We make software that transforms medical data into deeper insight. Our AI technology takes medical intelligence to the next level: data-driven medicine. We aim to solve the most critical issues in cancer care today: reduce medical cost and prolong ...
Predicting immunotherapy outcome with AI analysis; Finding more responders to cancer treatment; Tissue Data is huge and complex; Complex is what AI does ...